Skip to main content
. 2020 Jun 19;20:574. doi: 10.1186/s12885-020-07065-z

Table 1.

Secondary objectives of the HYPER-LIV01 trial

Tolerance
Post-operative mortality
Post-operative morbidity
Post-hepatectomy liver failure
Rate of non-resectability due to insufficient FRL
Rate of non-resectability due to tumor progression
Per-operative difficulties (adhesions, pedicular dissection …)
Blood loss, operating time, transfusions
R0 resection rate
Post-operative liver volume
Overall survival